The use of rehabilitation robots or alternate technologies for various physical therapies and cognitive impairments is growing fast. While hospitals and clinics globally offer robotic-assisted therapies, there is still a supply gap for reliable therapy robots or technology for home-care. Korean startup H Robotics wants to change the rehabilitation system by developing a sustainable robot solution that can quickly provide useful services to customers in their homes’ comforts. H Robotics is a robotics startup that develops home rehabilitation devices and remote rehabilitation services to treat patients with musculoskeletal and neurological conditions.
Rebless – the Home rehabilitation robot
H Robotics’s prime product Rebless was introduced at CES 2020 in Las Vegas, USA. Rebless is a home rehabilitation robot device and remote rehabilitation service for patients with musculoskeletal and neurological conditions. This healthcare device is seen as the new solution to the shortage of rehabilitation treatment. Most patients needing musculoskeletal and neurological rehabilitation go through intermittent outpatient rehabilitation treatment after some period of hospitalization. However, Rebless allows these patients to receive constant physical rehabilitation treatment in the comforts of their homes before visiting an outpatient clinic. Rebless greatly aids patients in their muscle and nervous system recovery.
Ribless can be used on the elbow, wrist, ankle, or knee to help musculoskeletal and neurological patients to recover muscle and joint movement at a constant speed. The device moves fluidly based on the patients’ assistance or resistance movements during its exercise assist mode. The device also captures rehabilitation data based on the patient’s torque and range of motion and displays the data collected through the app.
Remote medical treatment
The rehabilitation data collected by Rebless can be sent through the web to physicians, allowing them to grasp the patient’s condition. The device has an inbuilt remote medical treatment function that enables you to receive professional services from physicians at your own home. It allows patients and their caregivers to perform proper rehabilitation training recommended by the medical staff or rehabilitation therapist through Rebless. Also, since the device stores its medical data in the cloud, patients can repeat the recommended rehabilitation training and work to improve its effectiveness through the feedback and verification of therapists also stored in the cloud.
International Expansion & Future Goals
From its start in November 2018, H Robotics has won $6 billion in investments through producing high-tech robot technology that venture capitalists love. H Robotics has enjoyed success in the international scene, being selected to participate in CES2020 held in Las Vegas, USA, and enter the European market as a supporting company. In April of this year, the company was selected to take part in the “Development and Advancement Intermediate Research of Upper Limb Rehabilitation Robot capable of Flat Movement Research” as an intermediary. The study was conducted by the National Rehabilitation Center and is expected to produce excellent results in localizing upper limb rehabilitation robots and expanding rehabilitation treatment opportunities in the future. The startup aims to develop and commercialize “Home Rehabilitation Robots and Platforms” that enable more comfortable and effective rehabilitation for those who need rehabilitation treatment.
H Robotics plans to enter the European market through a partnership with the Small and Medium Venture Business Corporation. The move was meant to take advantage of the growing rehabilitation equipment market in the region. Europe has the most considerable need for rehabilitation devices to alleviate pressure on its outpatient services, followed by Asia. H Robotics was selected as a startup support business company for ‘KSC Finland,’ managed by the Ministry of Small and Medium Venture Business and Mid-Vacuum. H Robotics is currently participating in KSC Finland’s 10-week regular program, after which it’s set to receive support to enter the European market-based in Finland. The expansion is part of its current strategy to join the growing rehabilitation exercise device’s global market through Rebless.
Also Read more about Korean startups,
- Neofect – Company making ‘Rehabilitation Robotic Arm’ set to launch its IPO
- Angel Robotics: The ‘Angel Suits’ for those who can’t walk
- ExoAtlet Asia: Giving Wings to those who can’t walk
